Promega Denied Do-Over On $52M Gene-Testing Patent Verdict

Law360, Los Angeles (April 22, 2013, 10:53 PM EDT) -- A Wisconsin federal judge on Monday denied Promega Corp.’s bid for a new trial in its patent infringement suit over gene-testing technology after a $52 million jury verdict for Promega was vacated, saying Promega had already “forfeited” the argument.

The decision comes almost two months after Promega argued for relief from judgment and pressed for a new trial, saying that after a first trial was held to consider claims that Life Technologies Corp.’s genetic testing kits infringed Promega’s patents, new evidence came to light in a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.